This comparative analysis evaluates ceftriaxone efficacy in three brands against Escherichia coli, indicating significant differences in effectiveness.
Objective: This study compares the efficacy of three commercially available ceftriaxone brands in Libya (from Tunisia, Spain, and India) against Escherichia coli using minimal inhibitory concentration (MIC) assays. Methods: A susceptible strain of E. coli was tested following CLSI protocols. MIC values were determined using serial two-fold dilutions of ceftriaxone in Mueller-Hinton broth. Experiments were conducted in triplicate under controlled laboratory conditions.Results: The Spanish and Indian brands exhibited lower MIC values (0.1172–0.2344 mcg/mL), indicating higher efficacy, while the Tunisian brand showed reduced efficacy with MIC values (2.7581 mcg/mL) exceeding standard benchmarks. Conclusions: These findings underscore the variability in the efficacy of ceftriaxone brands, emphasizing the need for stringent quality control and standardized testing.
No takes yet. Share an insight, caveat, or question.
Egfier et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: